Podcasts about pharmd

On this episode, we discuss osteoarthritis and describe its clinical presentations, etiologies, and underlying pathophysiology.  We review current guidelines and evidence-based treatment strategies for managing osteoarthritis, including pharmacological and nonpharmacological interventions. We also compare and contrast the efficacy, safety profiles, and appropriate use of pharmacologic therapies, physical modalities, and lifestyle interventions in the treatment of osteoarthritis.  Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We have continued to partner with freeCE.com to provide listeners with the opportunity to claim 1-hour of continuing education credit for select episodes. For existing Unlimited (Gold) freeCE members, this CE option is included in your membership benefits at no additional cost! A password, which will be given at some point during this episode, is required to access the post-activity test. To earn credit for this episode, visit the following link below to go to freeCE's website: https://www.freece.com/ If you're not currently a freeCE member, we definitely suggest you explore all the benefits of their Unlimited Membership on their website and earn CE for listening to this podcast. Thanks for listening! If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. If you purchase an annual membership, you'll also get a free digital copy of High-Powered Medicine 3rd edition by Dr. Alex Poppen, PharmD. HPM is a book/website database of summaries for over 150 landmark clinical trials.You can visit our Patreon page at the website below:  www.patreon.com/corconsultrx We want to give a big thanks to Dr. Alex Poppen, PharmD and High-Powered Medicine for sponsoring the podcast..  You can get a copy of HPM at the links below:  Purchase a subscription or PDF copy - https://highpoweredmedicine.com/ Purchase the paperback and hardcover - Barnes and Noble website We want to say thank you to our sponsor, Pyrls. Try out their drug information app today. Visit the website below for a free trial: www.pyrls.com/corconsultrx We also want to thank our sponsor Freed AI. Freed is an AI scribe that listens, prepares your SOAP notes, and writes patient instructions. Charting is done before your patient walks out of the room. You can try 10 notes for free and after that it only costs $99/month. Visit the website below for more information: https://www.getfreed.ai/  If you have any questions for Cole or me, reach out to us via e-mail: Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com

In this episode, Sheila Arquette, President & CEO of NASP, speaks with David G. Mitchell, PharmD, MBA, CSP, FCPhA, Assistant Chief Pharmacy Officer of Specialty Pharmacy & Home Delivery and Ruth Chen, PharmD, MHA, Manager of the Specialty Pharmacy Hub at UC Davis Health in Sacramento. They look at how UC Davis Health has built and scaled one of California's most integrated health-system specialty pharmacy programs. Dr. Mitchell shares how being embedded within clinics, care teams, and the EHR enables specialty pharmacy to deliver differentiated clinical and operational value while navigating payer, policy, and access challenges in a rapidly evolving landscape. Dr. Chen discusses why a focused rare disease strategy is essential for health-system specialty pharmacies. She walks through the challenges that existed prior to implementing a centralized rare disease hub model and how those challenges shaped the development of a coordinated, pharmacy-led approach that supports patients and providers across complex therapies. Together, this conversation highlights how structure, strategy, and leadership enable innovation, workforce growth, and improved patient care.

Welcome back to Dr. M's Women and Children Firsts Podcast. Today's conversation sits at the crossroads of chemistry, skepticism, and clinical innovation. Our guest is Nayan Patel, a pharmacist with more than three decades inside the world of drug formulation and delivery. He is an alumnus of the University of Southern California School of Pharmacy, where he now serves as adjunct faculty, teaching advanced biochemistry and compounding science. Over the years, he has become an international educator on one molecule that refuses to stay quiet: glutathione. Dr. Patel is the founder of Auro Wellness, launched in 2011 with a specific mission—stabilize glutathione and solve its delivery problem. His work led to the development of the Auro GSH™ Antioxidant Delivery System, a topical approach designed to improve absorption of this notoriously fragile molecule. He is also the author of The Glutathione Revolution, a deep dive into how glutathione influences detoxification, aging, energy production, and immune resilience. If you've spent time in integrative medicine, you've heard glutathione called the “master antioxidant.” That phrase can sound like marketing, but the biology is real. Glutathione is a three–amino acid peptide central to redox balance, mitochondrial function, immune signaling, and cellular survival. It does not just neutralize oxidative stress; it regulates how cells respond to it. The challenge is delivery. Oral glutathione is largely broken down in the gut. IV glutathione works, but it's impractical for most families. Precursors like NAC depend on intact metabolic pathways that may not be operating optimally in states of chronic stress or inflammation. Dr. Patel asked a disruptive question: what if the bottleneck isn't production—but delivery? Today we unpack the science and the skepticism around transdermal glutathione. Can a molecule like this meaningfully cross the skin barrier? What does stabilization actually require? And how does independent pharmaceutical innovation differ from traditional drug development pathways, which are often constrained by economics as much as biology? For those of us caring for women and children—where oxidative stress, immune dysregulation, mitochondrial strain, and toxic burden intersect in everything from complicated pregnancies to neurodevelopmental challenges—this conversation matters. Not as a silver bullet. Not as a miracle spray. But as an exploration of foundational physiology and thoughtful delivery science. This is a discussion about how molecules move, how systems adapt, and how asking better questions can reshape clinical practice. Let's dive in. Dr. M Auro Wellness

In this episode, Scott Knoer, PharmD, MS, FASHP, Regional Chief Pharmacy Officer, shares how he is transforming pharmacy at MercyOne by building ambulatory and specialty infrastructure, strengthening leadership teams, and driving improvement in both outcomes and the system's bottom line.

On this episode, we define obesity and overweight status and describe their clinical impact, etiologies, and underlying pathophysiology. We also compare and contrast the efficacy, safety profiles, mechanisms of action, and appropriate use of available weight loss medications and nonpharmacologic approaches. Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We have continued to partner with freeCE.com to provide listeners with the opportunity to claim 1-hour of continuing education credit for select episodes. For existing Unlimited (Gold) freeCE members, this CE option is included in your membership benefits at no additional cost! A password, which will be given at some point during this episode, is required to access the post-activity test. To earn credit for this episode, visit the following link below to go to freeCE's website: https://www.freece.com/ If you're not currently a freeCE member, we definitely suggest you explore all the benefits of their Unlimited Membership on their website and earn CE for listening to this podcast. Thanks for listening! If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. If you purchase an annual membership, you'll also get a free digital copy of High-Powered Medicine 3rd edition by Dr. Alex Poppen, PharmD. HPM is a book/website database of summaries for over 150 landmark clinical trials.You can visit our Patreon page at the website below:  www.patreon.com/corconsultrx We want to give a big thanks to Dr. Alex Poppen, PharmD and High-Powered Medicine for sponsoring the podcast..  You can get a copy of HPM at the links below:  Purchase a subscription or PDF copy - https://highpoweredmedicine.com/ Purchase the paperback and hardcover - Barnes and Noble website We want to say thank you to our sponsor, Pyrls. Try out their drug information app today. Visit the website below for a free trial: www.pyrls.com/corconsultrx We also want to thank our sponsor Freed AI. Freed is an AI scribe that listens, prepares your SOAP notes, and writes patient instructions. Charting is done before your patient walks out of the room. You can try 10 notes for free and after that it only costs $99/month. Visit the website below for more information: https://www.getfreed.ai/  If you have any questions for Cole or me, reach out to us via e-mail: Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com

This INSIGHTS episode revisits a core topic from Neurocritical Care ON CALL®, originally released in August 2023.  Listen to the third episode of the NCS INSIGHTS series on acute ischemic stroke (part 1 of 2). The INSIGHTS series is hosted by Casey Albin, MD, and Salia Farrokh, PharmD, and covers topics from Neurocritical Care ON CALL®, the only up-to-date, comprehensive resource dedicated exclusively to the practice of neurocritical care. Learn more about ON CALL®. This episode is sponsored by Biogen. Science that transforms patient lives. Science that seeks to solve societal problems. Science that acts with purpose. Science that is inspired by the diversity and passion of our people. Discover where science meets humanity at Biogen. The NCS Podcast is the official podcast of the Neurocritical Care Society. The views expressed on the NCS Podcast are solely those of the hosts and guests and do not necessarily reflect the opinions or official positions of the Neurocritical Care Society.

In this episode, we sit down with a past president of the American Society of Consultant Pharmacists (ASCP) for an insightful conversation on leadership and caring for older adults.    We also dive into what it means to be an age-friendly pharmacist, exploring how the Age-Friendly Health Systems framework and the 4Ms can be applied in real-world pharmacy settings.  Finally, we break down how pharmacists can earn their Age-Friendly Pharmacist badge. Get your Age-Friendly Pharmacist Badge here:  https://www.ascp.com/page/agefriendly Tamara Ruggles, PharmD, BCGP, FASCP: www.linkedin.com/in/tamara-ruggles-491882251 Deborah A Milito, Pharm D, BCGP, FASCP, Age-Friendly Pharmacist:  https://www.linkedin.com/in/deborah-milito-32a28156/  

In this episode, Sahil Sheth, PharmD, BCCCP, Senior Director of Pharmacy Services at Luminis Health, discusses restructuring pharmacy leadership, expanding ambulatory and clinical pharmacy services, and strengthening operations across the system.

In this episode, John Pastor, PharmD, President of Fairview Pharmacy Services, discusses the system's major shared services expansion, investments in advanced pharmacy technology, and efforts to improve patient access amid widespread pharmacy closures. He also shares how Fairview is planning for growth while navigating workforce, supply chain, and policy headwinds.

TWIRx – January 30 | Special Guest: Marc Essensa, CEO of IPC On this episode of This Week in Pharmacy, we welcome Marc Essensa, President and CEO of the Independent Pharmacy Cooperative (IPC), to discuss timely strategies and resources helping independent pharmacies strengthen their businesses in today's challenging environment. Building Your Independent Pharmacy Business Marc shares insights on navigating reimbursement pressure, improving margins, and leveraging IPC's purchasing power, data, and strategic tools to support long-term sustainability. The Payment Card Settlement: A Practical Guide We break down IPC's guidance on the Payment Card Interchange Fee Settlement, which may allow pharmacies that accepted Visa or Mastercard between 2004–2019 to recover funds. Marc explains eligibility, next steps, and how recovered dollars can support cash flow, staffing, technology, or inventory investments. IPC Member Support Services The conversation highlights IPC's expanded member support offerings, including business consulting, strategic partnerships, wholesale access, and operational resources designed to help independents stay competitive. Legislative & Advocacy Updates Marc also provides updates on IPC's advocacy efforts at both the state and federal levels, focused on protecting independent pharmacy interests and addressing ongoing policy and reimbursement challenges.

In today's episode, Neil Iyengar, MD, moderated an OncLive Insights discussion about adverse effect management when using breast cancer therapies targeting the PI3K, AKT, and mTOR pathways. Dr Iyengar is an associate professor in the Department of Hematology and Medical Oncology and co-director of Breast Medical Oncology in the Department of Hematology and Medical Oncology at Emory University School of Medicine; as well as director of Survivorship Services at the Winship Cancer Institute of Emory University in Atlanta, Georgia. He was joined by Heather Moore, CPP, PharmD, a clinical pharmacist practitioner at the Duke Cancer Center Breast Clinic in Durham, North Carolina; and Sarah Donahue, MPH, NP, a nurse practitioner at the University of California San Francisco Health.  In our exclusive discussion, the experts highlighted the importance of early and comprehensive testing (using both tissue and liquid biopsies) for genetic alterations to guide treatment decisions. They also noted strategies for managing diarrhea, including patient education on diet, proactive use of loperamide, and regular monitoring. They also explained that hyperglycemia management should hinge on prophylactic use of metformin or SGLT2 inhibitors, dietary restrictions, and frequent glucose monitoring. Their conversation on rash management included insights about prophylactic antihistamines, patient education on skin care, and involving dermatology for severe cases. Overall, the experts spotlighted the importance of multidisciplinary collaboration and proactive patient education when treating patients with breast cancer.

Dr. Emlah Tubuo shares how intentional living, whole-person care, and mindset are reshaping pharmacy, leadership, and personal wellbeing. Episode Summary In this episode of the YFP Podcast, Tim Ulbrich, PharmD sits down with Dr. Emlah Tubuo to explore what intentional living looks like in real life and in modern pharmacy practice. Emlah shares how Powell Pharmacy has evolved beyond dispensing into whole-person care, including biomarker testing, hormone optimization, and integrated wellness services. They discuss resilience, mindset, and how pharmacists can reclaim purpose by meeting patients where they are, while also addressing burnout, fear, and the power of being fully present. Whether you are a pharmacist, entrepreneur, or someone seeking a more aligned and intentional life, this conversation offers both inspiration and practical insight. What you'll learn in this episode: How intentional living can transform pharmacy practice and patient care Why whole-person care goes beyond prescriptions and lab values alone Practical ways pharmacists can integrate biomarkers, hormones, and wellness initiatives How mindset, presence, and resilience reduce burnout and improve impact What it means to redefine success through service, alignment, and purpose Mentioned on the Show Powell Pharmacy Journeys Lab Testing for Pharmacists Pharmacist Fullscript Account Setup Lunch and Learn Supplement Knowledge Discuss Dietary Supplements With Confidence Intentional Living Newsletter Emlah Naturals Intentional Living Podcast Emlah Tubuo - LinkedIn Emlah Tubuo - Instagram

In this powerful episode of MaternalRx on the Pharmacy Podcast Network, host Danielle Plummer, PharmD, speaks with pharmacist Willie Bawarski and his wife, Olivia, about their deeply personal journey through infertility, IVF treatment, foster care, and adoption. Willie and Olivia share the emotional, physical, and financial realities of trying to conceive, navigating fertility treatments, and facing the grief that often accompanies infertility. When their path to parenthood changed, they chose to open their hearts and home through foster care and adoption, ultimately building a beautiful family in ways they never expected. This conversation highlights the critical role pharmacists and healthcare professionals play in supporting patients experiencing infertility and those considering foster care or adoption. Listeners will gain practical insight into using compassionate language, empathy, and trauma-informed care to support individuals and couples during some of the most vulnerable seasons of their lives. Whether you are facing infertility, exploring IVF, considering adoption, working within maternal health, or caring for patients on these journeys, this episode offers hope, validation, and a reminder that family is defined by love, not biology.

This INSIGHTS episode revisits a core topic from Neurocritical Care ON CALL®, originally released in July 2023.  Listen to the second episode of the NCS INSIGHTS series on status epilepticus (part 2 of 2). The INSIGHTS series is hosted by Casey Albin, MD, and Salia Farrokh, PharmD, and covers topics from Neurocritical Care ON CALL®, the only up-to-date, comprehensive resource dedicated exclusively to the practice of neurocritical care. Learn more about ON CALL®. This episode is sponsored by Ceribell. Time is brain when it comes to seizures. Ceribell point-of-care EEG empowers the bedside team to detect or rule out seizure activity in minutes. To learn more, visit ceribell.com. The NCS Podcast is the official podcast of the Neurocritical Care Society. The views expressed on the NCS Podcast are solely those of the hosts and guests and do not necessarily reflect the opinions or official positions of the Neurocritical Care Society.

Could low cortisol be the hidden reason behind chronic fatigue, poor stress tolerance, sleep disruptions, or mood changes? Cortisol is often misunderstood as just a “stress hormone,” but it plays a critical role in regulating energy levels, emotional resilience, inflammation, and the body's natural sleep-wake cycle. When cortisol production becomes depleted due to prolonged stress, illness, or trauma, the body may struggle to function optimally, leading to symptoms commonly associated with adrenal insufficiency. Join us today as Bryana Gregory, PharmD, RPh, Pharmacist and Physician Liaison at Physicians Preference Pharmacy, explains how compounded oral cortisol can be used as a personalized hormone replacement option to support adrenal function. She walks through how cortisol naturally follows a diurnal rhythm, why low levels can disrupt sleep and energy, and how carefully dosed replacement may help restore balance. The discussion also highlights how compounded formulations allow for individualized dosing, cleaner ingredients, and delivery methods that better mimic the body's natural cortisol patterns. Listeners will gain insight into who may benefit from cortisol replacement, how it differs from adrenal supplements, and why more is not always better when it comes to hormone therapy. This episode emphasizes the importance of working closely with a knowledgeable physician to address symptoms, monitor response, and create a customized approach that supports long-term wellness, resilience, and overall quality of life. To learn more, visit www.PhysiciansPreferenceRX.com or call 281-828-9088. Watch now and subscribe to our podcasts at www.HotzePodcast.com. To receive a FREE copy of Dr. Hotze's best-selling book, “Hormones, Health, and Happiness,” call 281-698-8698 and mention this podcast. Includes free shipping!

Could medications originally designed for diabetes actually help treat addiction, eating disorders, and the biology of cravings?In this part 2 of 2-part episode of Succeed In Medicine Podcast, Dr. Bradley Block sits down with Dr. Sean Wharton, to dig deeper into the science, myths, and emerging uses of GLP-1 agonists. Dr. Wharton explains that these medications don't simply reduce appetite, they calm what he calls “food noise,” the constant mental pull toward eating that many people with obesity experience. This neurological effect has opened the door to exciting possibilities: early research suggests GLP-1 drugs may also reduce cravings for alcohol and other addictive behaviors.  Dr. Wharton also clarifies the confusing world of brand names. Ozempic and Wegovy are both semaglutide; Mounjaro and Zepbound are tirzepatide. The differences are largely about FDA indications and insurance coverage, not completely different medications.The episode tackles common fears patients and clinicians hear every day. Do these medications cause eating disorders? No, in fact, they may help treat them. Are the side effects dangerous? Usually not, and most are manageable with proper dosing. Is “Ozempic face” real? It's simply normal fat loss, not a drug-specific problem. Most importantly, Dr. Wharton reinforces a compassionate, evidence-based message: obesity is a chronic, biological disease, and GLP-1 medications are tools to treat it, just like medications for blood pressure or diabetes.Three Actionable TakeawaysGLP-1 Medications Affect the Brain as Much as the Stomach: These drugs reduce “food noise” and cravings, helping patients regain control over eating behaviors. Their impact is neurological, not simply about willpower or restriction.Side Effects Are Real—but Usually Manageable: Nausea, constipation, and GI symptoms are the most common issues, especially early on. Starting low and increasing doses slowly makes treatment far more tolerable.Treatment Decisions Should Be Individualized:  Not every patient must stay on these medications forever. Conversations about duration, goals, and expectations should be collaborative and tailored to each person.About the Show:Succeed In Medicine covers patient interactions, burnout, career growth, personal finance, and more. If you're tired of dull medical lectures, tune in for real-world lessons we should have learned in med school!About the Guest:Dr. Sean Wharton holds doctorates in Pharmacy and Medicine from the University of Toronto. He is the Director of the Wharton Medical Clinic, a community-based weight management and diabetes clinic, and serves as Assistant Professor at the University of Toronto and Adjunct Professor at McMaster and York Universities.Dr. Wharton is the lead author of the 2020 Canadian Obesity Guidelines, recognized worldwide, and has published extensively in major medical journals including the New England Journal of Medicine. He is a passionate advocate for health equity and improving the way obesity is understood and treated in healthcare.LinkedIn: linkedin.com/in/drseanwhartonWebsite: whartonmedicalclinic.comAbout the Host:Dr. Bradley Block – Dr. Bradley Block is a board-certified otolaryngologist at ENT and Allergy Associates in Garden City, NY. He specializes in adult and pediatric ENT, with interests in sinusitis and obstructive sleep apnea. Dr. Block also hosts Succeed In Medicine podcast, focusing on personal and professional development for physiciansWant to be a guest?Email Brad at brad@physiciansguidetodoctoring.com  or visit www.physiciansguidetodoctoring.com to learn more!Socials:@physiciansguidetodoctoring on Facebook@physicianguidetodoctoring on YouTube@physiciansguide on Instagram and Twitter  This medical podcast is your physician mentor to fill the gaps in your medical education. We cover physician soft skills, charting, interpersonal skills, doctor finance, doctor mental health, medical decisions, physician parenting, physician executive skills, navigating your doctor career, and medical professional development. This is critical CME for physicians, but without the credits (yet). A proud founding member of the Doctor Podcast Network!Visit www.physiciansguidetodoctoring.com to connect, dive deeper, and keep the conversation going. Let's grow! Disclaimer:This podcast is for informational purposes only and is not a substitute for professional medical, financial, or legal advice. Always consult a qualified professional for personalized guidance. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

DESCRIPTIONIn this episode of the FIT40 Podcast, I'm joined by Dr. Ashley Dwyer to break down the new nutrition guidelines and why they're confusing so many women over 40. We talk protein needs, fiber intake, gut health, saturated fat, carbs, and the rise of nutrition misinformation online. Ashley explains what actually matters for fat loss, heart health, and digestion after 40, why extreme diets backfire, and how to build a realistic, evidence-based approach that fits busy real life. If you're tired of conflicting advice and want clarity without extremes, this episode is a must-listen.HOW TO FIND DR DWYERInstagram: https://www.instagram.com/dr.dwyerFIT40 LINKS✅ Feeling low on energy and out of shape but short on time?

John Schoen, Senior Clinical Manager of Evidence-Based Medicine and Drug Information in Vizient's Center for Pharmacy Practice Excellence and Vizient's vaccine subject matter expert, joins host Stacy Lauderdale to discuss key updates to the CDC's childhood Immunization schedule and what they mean for practice.   Guest speaker:     John Schoen, PharmD, BCPS   Senior Clinical Manager of Evidence-Based Medicine and Drug Information    Vizient Center for Pharmacy Practice Excellence     Host:   Stacy Lauderdale, PharmD, BCPS   Associate Vice President  Vizient Center for Pharmacy Practice Excellence   Verified Rx Host    00:00 — Introduction Announcer welcomes listeners to Verified Rx, produced by the Vizient Center for Pharmacy Practice Excellence. 00:14 — Episode Overview Host Stacy Lauderdale introduces the topic: updates to the CDC's U.S. Childhood Immunization Schedule, revised January 20, 2026. Goal of the episode: explain what changed, what didn't, and what it means in practice for providers, pharmacists, and families. Guest: John Schoen, Senior Clinical Manager of Evidence-Based Medicine and Drug Information at Vizient and vaccine subject matter expert. 01:16 — What Changed in the CDC Immunization Schedule CDC reorganized the schedule into three recommendation categories. Vaccines were reclassified, not removed. Number of diseases covered under “routine” recommendations decreased from 17 to 11 due to recategorization. 01:50 — Stated Rationale Behind the Changes Rationale provided in executive summary of scientific assessment. The supporting scientific assessment is available online and referenced for transparency (link in resources below). 03:19 — Were Any Vaccines Removed? No vaccines were removed from the CDC schedule. Some vaccines were shifted into different recommendation categories. 03:40 — Category 1: Routine Childhood Vaccinations Vaccines still routinely recommended for all children include: MMR (measles, mumps, rubella) Polio Tdap / DTaP Hib (Haemophilus influenzae type B) Pneumococcal HPV Varicella (chickenpox) 04:27 — Category 2: Vaccines for High-Risk Populations Vaccines recommended for children who meet specific high-risk criteria: RSV monoclonal antibodies (mAb) Hepatitis A Hepatitis B Quadrivalent meningococcal Meningococcal group B Dengue 05:19 — What Changed vs. Stayed the Same Hepatitis A, Hepatitis B, and quadrivalent meningococcal moved from routine to high-risk RSV mAb recommendations are effectively unchanged, as high-risk infants are defined as those born to mothers who did not receive the maternal RSV vaccine. Dengue remains risk-based. Meningococcal group B remains a mix of risk-based and shared clinical decision-making. 06:31 — Category 3: Shared Clinical Decision Making (SCDM) Defined by ACIP as an individualized decision made jointly by provider and parent/guardian. Allows vaccination when risk-based criteria are not met but benefit is still considered. 06:52 — Vaccines Under SCDM Vaccines now include: Influenza COVID-19 Rotavirus Hepatitis A Hepatitis B Quadrivalent meningococcal Meningococcal group B 08:05 — What's New in SCDM Influenza and rotavirus moved from routine to SCDM. Hepatitis A, hepatitis B, and quadrivalent meningococcal also shifted. COVID-19 moved to SCDM in September 2025 for individuals ≥6 months. 08:28 — Insurance Coverage Implications No expected changes in coverage. Vaccines recommended by CDC as of December 31, 2025 remain: Covered without cost-sharing under Affordable Care Act (ACA) plans. Covered by Medicaid, Children's Health Insurance Program (CHIP), and Vaccines for Children (VFC) program. 09:14 — Impact on Pharmacy Vaccine Access Pharmacists are considered healthcare providers under CDC SCDM definitions. Authority to administer vaccines primarily determined by state laws. Standing orders, protocols, and collaborative practice agreements may need to be updated, as applicable, to address language related to ‘routine' immunizations for children. 10:27 — Recommendations for Providers & Organizations For providers: Become familiar with schedule changes. Be prepared for patient and parent education. Recognize differences between CDC and other professional guidelines. For organizations: Review EHR documentation and order sets. Consult local state regulations to ensure compliance with vaccine administration practices. Review standing orders/protocols and collaborative practice agreements to determine if revisions are needed. Monitor vaccine utilization and adjust inventory accordingly. 11:24 — Resources & Closing Additional CDC and Vizient resources will be linked in the show notes. Announcer closes with subscription and feedback reminder. Links | Resources:    Additional resources HHS press release on changes to childhood immunizations schedule Assessment of US childhood and adolescent immunization schedule HHS fact sheet: CDC childhood immunization schedule Revised CDC child and adolescent immunization schedule ACIP shared clinical decision-making recommendations   Vizient resource Minute Market Insight   VerifiedRx Listener Feedback Survey: We would love to hear from you - Please click here   Subscribe Today! Apple Podcasts Spotify YouTube RSS Feed  

On this episode, we define hypothyroidism and hyperthyroidism and describe their clinical presentations, etiologies, and underlying pathophysiology. We also evaluate current guidelines and evidence-based treatment strategies for the management of hypothyroidism and hyperthyroidism. Then, we compare and contrast the efficacy, safety profiles, and appropriate use of therapies for thyroid disorders, including hormone replacement, antithyroid medications, radioactive iodine, and monitoring strategies.  Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We have continued to partner with freeCE.com to provide listeners with the opportunity to claim 1-hour of continuing education credit for select episodes. For existing Unlimited (Gold) freeCE members, this CE option is included in your membership benefits at no additional cost! A password, which will be given at some point during this episode, is required to access the post-activity test. To earn credit for this episode, visit the following link below to go to freeCE's website: https://www.freece.com/ If you're not currently a freeCE member, we definitely suggest you explore all the benefits of their Unlimited Membership on their website and earn CE for listening to this podcast. Thanks for listening! If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. If you purchase an annual membership, you'll also get a free digital copy of High-Powered Medicine 3rd edition by Dr. Alex Poppen, PharmD. HPM is a book/website database of summaries for over 150 landmark clinical trials.You can visit our Patreon page at the website below:  www.patreon.com/corconsultrx We want to give a big thanks to Dr. Alex Poppen, PharmD and High-Powered Medicine for sponsoring the podcast..  You can get a copy of HPM at the links below:  Purchase a subscription or PDF copy - https://highpoweredmedicine.com/ Purchase the paperback and hardcover - Barnes and Noble website We want to say thank you to our sponsor, Pyrls. Try out their drug information app today. Visit the website below for a free trial: www.pyrls.com/corconsultrx We also want to thank our sponsor Freed AI. Freed is an AI scribe that listens, prepares your SOAP notes, and writes patient instructions. Charting is done before your patient walks out of the room. You can try 10 notes for free and after that it only costs $99/month. Visit the website below for more information: https://www.getfreed.ai/  If you have any questions for Cole or me, reach out to us via e-mail: Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com

In this episode, Todd Karpinski, PharmD, MS, FASHP, FACHE, System Vice President and Chief Pharmacy Officer at WVU Medicine, joins the podcast to discuss the evolving pharmacy landscape. He shares perspectives on ongoing challenges with retail pharmacy reimbursements, addressing staffing shortages, and how strategic partnerships can support sustainable growth and strengthen pharmacy operations across the health system.

On this episode host Fred Goldstein invites Angela Luong, PharmD, Senior Clinical Consultant at Pharmaceutical Strategies Group in this last installment of our rare disease series. Our discussion focuses on the burden of sickle cell disease, chronic pain management, limited treatment options, and the implications for managed care programs, including the use of data and care coordination to improve patient outcomes. This activity is supported by an independent medical education grant from Agios Pharmaceuticals, Inc. AMCP offers CPE for this podcast through December 31, 2026. For additional information and to claim credit, please visit: The Power of Partnership: Bridging Patients and Payers in Sickle Cell Disease Management. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

In this episode, Justin L. Vesser, PharmD, MS, Director of Ambulatory Pharmacy at UVA Health, shares how his team expanded clinical pharmacy services, improved medication access, and grew retail operations to better serve patients across Virginia. He also discusses navigating reimbursement pressures, regulatory headwinds, and leading through change by anchoring pharmacy teams in a clear mission.

In this episode, Bethanie Stein, PharmD, Segment President of Pharmacy at Humana, discusses how employers are approaching GLP-1 coverage and why partnerships with manufacturers like Eli Lilly and Novo Nordisk matter now. She shares how CenterWell Pharmacy is using transparency, clinical oversight, and adherence focused models to expand access while managing costs.

In this episode, Roya Tran, PharmD, MS, 340B ACE, Associate Chief Pharmacy Officer for Pharmacy Finance and Supply Chain at Duke Health, joins the podcast to discuss her experience with the 340B program and how it supports access to care. She shares perspectives on expanding the ambulatory pharmacy space, identifying growth opportunities, and improving access to pharmaceutical care through strategic finance and supply chain alignment.

In this episode, Edith Okolo, PharmD, RPh, Director of Pharmacy at Cedar Crest Hospital, joins the podcast to discuss pharmacy priorities heading into 2026, with patient safety at the forefront. She shares insights on improving workflow efficiency, addressing medication affordability—particularly long-acting injectables—and navigating ongoing medication shortages and broader industry challenges.

This INSIGHTS episode revisits a core topic from Neurocritical Care ON CALL®, originally released in July 2023.  Listen to the first episode of the NCS INSIGHTS series on status epilepticus (part 1 of 2). The INSIGHTS series is hosted by Casey Albin, MD, and Salia Farrokh, PharmD, and covers topics from Neurocritical Care ON CALL®, the only up-to-date, comprehensive resource dedicated exclusively to the practice of neurocritical care. Learn more about ON CALL®. This episode is sponsored by Ceribell. Time is brain when it comes to seizures. Ceribell point-of-care EEG empowers the bedside team to detect or rule out seizure activity in minutes. To learn more, visit ceribell.com. The NCS Podcast is the official podcast of the Neurocritical Care Society. The views expressed on the NCS Podcast are solely those of the hosts and guests and do not necessarily reflect the opinions or official positions of the Neurocritical Care Society.

I'm celebrating 6 years in podcasting today!

In this episode, Nick Gazda, PharmD, MS, BCPS, CSP, Director of Pharmacy Oncology and Infusion at Cone Health, discusses how standardized infusion services, centralized medication access, and technology integration have improved patient care and operational efficiency. He also shares strategies for navigating financial and regulatory headwinds while pursuing growth and value-based opportunities in 2026.

Send us a textSchedule an Rx AssessmentAI in pharmacy isn't about prompts, dashboards, or “nice-to-have” tools, it's about execution.In this episode of the Bottom Line Pharmacy Podcast, Austin Murray sits down with Natalie Park, PharmD, co-founder and CEO of Pharmesol, to break down what AI agents actually are and why they represent a major shift in how pharmacies operate, scale, and compete.We uncover: What an AI agent really isHow AI agents can execute workflowsHow automation is driving real revenue growthWhere pharmacies are seeing the biggest early winsAnd more!More About Our Guest:Dr. Natalie Park, Pharm.D. is a pharmacist, entrepreneur, and health technology innovator who exemplifies how a pharmacy degree can become a launchpad for transformative impact.A proud graduate of The Ohio State University College of Pharmacy, Natalie brings a bold, initiative-driven mindset to everything she does embracing challenges, valuing diverse experiences, and firmly believing that practice, not theory alone, drives meaningful change.Fueled by a passion for digital health, innovation, and health policy, Natalie is the founder and CEO of Pharmesol, an AI-powered pharmacy assistant designed to strengthen connections between practitioners and patients while improving access to care. Her interests span comparative effectiveness research, health technology assessment, and healthcare innovation, all with a focus on practical, real-world application.Natalie's journey into pharmacy is deeply personal. After moving to the U.S. as a teenager, she struggled to navigate the healthcare system. When she experienced an allergic reaction for the first time, she turned to a pharmacy—simply because she didn't know where else to go. That moment shaped her purpose and inspired her to pursue pharmacy as a pathway to accessible, patient-centered care.Today, as a technology CEO serving pharmacies, Natalie's work blends strategy, customer engagement, and problem-solving. She partners closely with pharmacy leaders to understand their needs, guides product innovation with intention, and keeps her team focused on delivering meaningful value. Her career is a testament to lifelong learning—not as something additive, but transformative—and to the idea that pharmacy isn't just a profession, but a platform for limitless possibilities.Stay connected with Natalie and Pharmesol:Natalie's LinkedInPharmesol WebsitePharmesol LinkedInStay connected with us:FacebookTwitterLinkedInScotty Sykes – CPA, CFP LinkedInScotty Sykes – CPA, CFP TwitterBonnie Bond – CPA LinkedInBonnie Bond – CPA TwitterMore resources on this topic:Podcast - Driving Independent Pharmacy Profitability in 2026Podcast – The Startup Compounding Pharmacy PlaybookPodcast – Inside the Fight for Compounding: Advocacy, Growth, and Regulation

The American Diabetes Association's 2026 Standards of Care in Diabetes are here! Let's talk about what's changed and how to better care for our older adults living with diabetes. 2026 Standards of Care in Diabetes:  https://diabetesjournals.org/care/issue/49/Supplement_1 Tamara Ruggles, PharmD, BCGP, FASCP:  www.linkedin.com/in/tamara-ruggles-491882251 Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES:  https://www.linkedin.com/in/diana-isaacs-pharmd-bcps-bcacp-bc-adm-cdces-45803426/  

Are GLP-1 medications truly revolutionizing medicine—or are we just seeing the latest healthcare hype cycle?In this part 1 of 2- part episode of Succeed In Medicine Podcast, Dr. Bradley Block sits down with Dr. Sean Wharton, to explore the real story behind GLP-1 agonists, how they were discovered, how they work, and why they suddenly became cultural blockbusters. Dr. Wharton explains that while the public sees these drugs as new, clinicians in diabetes care have been using them for over a decade. Originally developed to treat type 2 diabetes, GLP-1 medications revealed an unexpected benefit: meaningful weight loss. What began as a “sleeper drug” for glucose control became a global phenomenon once their impact on appetite and cravings was understood.A major theme of the discussion is the concept of “food noise”—the relentless mental pull toward food that many patients experience. Dr. Wharton describes how this biological drive makes long-term weight loss extraordinarily difficult and why willpower alone is rarely enough. GLP-1 medications work by quieting this food noise, helping patients regain control over their eating behaviors.The conversation also tackles tough questions clinicians and patients ask every day:Why do people need to stay on these medications long-term? Why do patients with diabetes lose less weight than those without? Is obesity truly a disease, and how should doctors talk about it? Are the benefits due to the drug itself or simply the weight loss? Dr. Wharton breaks down the biology of GLP-1 hormones, their role in insulin regulation and appetite control, and why these drugs have been such rare “unicorns” in medicine, highly effective with relatively few side effects.This episode sets the stage for Part 2, where they will dive deeper into myths, side effects, and practical prescribing guidance.Three Actionable TakeawaysObesity Is a Biological Disease, Not a Willpower Problem: Food noise and cravings are driven by hormones and brain chemistry. GLP-1 medications treat these biological mechanisms, not a character flaw.Long-Term Treatment Is Often Necessary: Just like medications for blood pressure or cholesterol, GLP-1 drugs address a chronic condition. Stopping treatment usually means the underlying biology—and weight—returns.Language Matters in Patient Care: Clinicians should approach weight with empathy and humility. Inviting patients into a respectful conversation about options is far more effective than blaming or shaming.About the Show:Succeed In Medicine covers patient interactions, burnout, career growth, personal finance, and more. If you're tired of dull medical lectures, tune in for real-world lessons we should have learned in med school!About the Guest:Dr. Sean Wharton holds doctorates in Pharmacy and Medicine from the University of Toronto. He is the Director of the Wharton Medical Clinic, a community-based weight management and diabetes clinic, and serves as Assistant Professor at the University of Toronto and Adjunct Professor at McMaster and York Universities.Dr. Wharton is the lead author of the 2020 Canadian Obesity Guidelines, recognized worldwide, and has published extensively in major medical journals including the New England Journal of Medicine. He is a passionate advocate for health equity and improving the way obesity is understood and treated in healthcare.LinkedIn: linkedin.com/in/drseanwhartonWebsite: whartonmedicalclinic.comAbout the Host:Dr. Bradley Block – Dr. Bradley Block is a board-certified otolaryngologist at ENT and Allergy Associates in Garden City, NY. He specializes in adult and pediatric ENT, with interests in sinusitis and obstructive sleep apnea. Dr. Block also hosts Succeed In Medicine podcast, focusing on personal and professional development for physiciansWant to be a guest?Email Brad at brad@physiciansguidetodoctoring.com  or visit www.physiciansguidetodoctoring.com to learn more!Socials:@physiciansguidetodoctoring on Facebook@physicianguidetodoctoring on YouTube@physiciansguide on Instagram and Twitter  This medical podcast is your physician mentor to fill the gaps in your medical education. We cover physician soft skills, charting, interpersonal skills, doctor finance, doctor mental health, medical decisions, physician parenting, physician executive skills, navigating your doctor career, and medical professional development. This is critical CME for physicians, but without the credits (yet). A proud founding member of the Doctor Podcast Network!Visit www.physiciansguidetodoctoring.com to connect, dive deeper, and keep the conversation going. Let's grow! Disclaimer:This podcast is for informational purposes only and is not a substitute for professional medical, financial, or legal advice. Always consult a qualified professional for personalized guidance. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

We're stepping out of our Medicine on the Go series for a rapid-response episode on something hitting all of us hard right now: **influenza**. A lively debate among our colleagues sparked this conversation—especially around a newer flu antiviral, baloxavir (Xofluza). Who's using it? When does it make sense? How much does it cost patients? And how does it really compare to the longtime staple oseltamivir (Tamiflu)? The questions came fast, the opinions were strong, and we knew it was time to dig in. With flu season in full swing, this episode is all about practical decision-making at the bedside. Back to Basics: How Flu Antivirals Work To help break it all down, we welcome back our trusted ED pharmacist, Haley Burhans. We begin with a quick review of how influenza antivirals have evolved. , approved in 1999, was the first widely used antiviral and works by blocking the neuraminidase enzyme. Over time, concerns about resistance led to the development of newer options. That brings us to baloxavir (Xofluza), approved in 2018. Xofluza works differently by stopping viral replication earlier in the virus life cycle. While both medications aim to shorten illness and reduce complications, they differ in how they work, how they are dosed, and which patients benefit most. Who Should Get What—and When? Next, we focus on real-world ED decision-making. Who should receive Tamiflu, and who is a good candidate for Xofluza? We review use in children, pregnant patients, hospitalized patients with severe or worsening illness, immunocompromised patients, and those at higher risk due to conditions like asthma, lung disease, diabetes, heart disease, obesity, or older age. Timing is critical. Both medications work best when started within 48 hours of symptom onset. However, oseltamivir is still recommended even after that window for patients who are hospitalized or severely ill. We also discuss when antivirals can be used for post-exposure prpphylaxis. What Does the Evidence Say? We then take a closer look at the data behind antiviral treatment. Both Tamiflu and Xofluza shorten the time to symptom improvement. Observational studies suggest oseltamivir may reduce hospital length of stay and in-hospital death in adults and shorten hospital stays in children. Trial data also suggest baloxavir may be more effective against influenza B. We compare dosing strategies—five days of twice-daily Tamiflu versus a single-dose Xofluza—and review side effects and pediatric considerations. Real-World Barriers: Access and Cost Finally, we tackle the practical issues clinicians face every day. Tamiflu is widely available and familiar to most providers. Xofluza, on the other hand, often requires prior authorization and may be harder for patients to obtain. We discuss insurance barriers, out-of-pocket costs, manufacturer coupons, and situations where Xofluza may or may not be a realistic option. Take-Home Message This episode is a practical, evidence-based conversation designed to help emergency clinicians make confident decisions during flu season. Whether you're treating a high-risk patient, considering a single-dose option for uncomplicated flu, or simply trying to stay current, this discussion delivers clear, useful guidance you can use on your next shift! What's your go to flu treatment? What other medications would you like to learn more about? Hit us up on social media @empulsepodcast or at ucdavisem.com Hosts: Dr. Julia Magaña, Professor of Pediatric Emergency Medicine at UC Davis Dr. Sarah Medeiros, Professor of Emergency Medicine at UC Davis Guests: Haley Burhans, PharmD, Emergency Medicine Clinical Pharmacist at UC Davis Resources: CDC: Influenza Antiviral Medications: Summary for Clinicians AAP: Recommendations for Prevention and Control of Influenza in Children, 2025–2026: Policy Statement ACEP Influenza Resources and Updates **** Thank you to the UC Davis Department of Emergency Medicine for supporting this podcast and to Orlando Magaña at OM Productions for audio production services.

What if financial success isn't about saving more, but aligning money with the life you want today? Episode Summary After years of doing "everything right" financially, many pharmacists reach a surprising crossroads: retirement feels on track, but something still feels off. In this solo episode, Tim Ulbrich, PharmD reflects on a counterintuitive decision he has made over the past five years by intentionally not maxing out traditional retirement accounts, and the deeper question that choice surfaced: what are you optimizing for right now? This conversation explores the tension between financial efficiency and life alignment, the concept of "enough," and why financial planning in mid-career is less about winning spreadsheets and more about finding a way to live your rich life today while preparing for the future. What you'll learn in this episode: Why "on track" financially doesn't always feel satisfying  The difference between accumulating wealth and being truly retirement-ready The hidden risk of always optimizing your financial plan for a future state at the expense of today Why "enough" is a decision, not just a number

In this month's podcast episode, The Standards, hosts Neil Skolnik, MD, and Sara Wettergreen, PharmD, BCACP, BC-ADM, explain the Standards of Care in Diabetes from the American Diabetes Association® in clear, plain terms. This conversation is designed to help you better understand the guidance that shapes diabetes and obesity care. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to "follow" Diabetes Day by Day!   Additional resources: Access the Standards of Care in Diabetes—2026 Access sections 1-3 of the Standards of Care in Overweight and Obesity Access Your Rights and Care Standards: A Guide for People with Type 2 Diabetes          

Send us a textSchedule an Rx AssessmentLevi is hiring! Interested in working for a pharmacy that runs on structure, relationships, and a high-performance Med Sync model (not “rat race” retail)? Click hereIf you really want to maximize your Med Sync program, you need to shift your mindset from "Med Sync is a “program” to "Med Sync is our culture and a competitive advantage."In this episode of the Bottom Line Pharmacy Podcast, Scotty Sykes, CPA, CFP®, Bonnie Bond, CPA, MBA, and Austin Murray sit down with Dr. Levi Ellison, PharmD, Owner of Ellison Family Pharmacy to discuss his Med Sync operation, how it's driving 42 inventory turns and creating a smoother, calmer experience for patients and staff.We break down:Med Sync as opt-out, not opt-inHow Med Sync creates financial leverageWhy Levi believes Med Sync benefits everyoneThe Med Sync workflow driving above average inventory turnsAnd more!More About Our Guest:Dr. Levi Ellison, PharmD is the owner of Ellison Family Pharmacy. An independent pharmacy located in Mena Arkansas.Levi's roots run deep in Polk County with his family going back six or more generations on both sides. Both Levi graduated with a Doctor of Pharmacy degree in 2018 from UAMS College of Pharmacy in Little Rock, AR. Levi serves as the pharmacist in charge of Ellison Family Pharmacy and Jessica works part time as a pharmacist.Levi is a very active member of Salem Baptist Church located in the community of Nunley just outside Mena. He is also a member of the Arkansas Pharmacists Association and the National Community Pharmacists Association. In his limited free time he enjoys spending time with wife Jessica hiking and with their children.Stay connected with Levi and Ellison Family Pharmacy: Levi's LinkedInEllison Rx WebsiteEllison Rx Facebook Stay connected with us: FacebookYouTube LinkedInInstagramMore resources on this topic: Podcast - Driving Independent Pharmacy Profitability in 2026Podcast – The Startup Compounding Pharmacy PlaybookPodcast – Inside the Fight for Compounding: Advocacy, Growth, and Regulation

On this episode, we discuss community-acquired pneumonia (CAP) and its clinical presentation, common etiologies, and underlying pathophysiology. We review current guidelines and evidence-based treatment recommendations for managing CAP, including diagnostic criteria, severity assessment tools, and appropriate antimicrobial selection. We also compare and contrast the efficacy, safety considerations, and appropriate use of antimicrobial therapies, supportive care measures, and monitoring strategies in the treatment of CAP. Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We have continued to partner with freeCE.com to provide listeners with the opportunity to claim 1-hour of continuing education credit for select episodes. For existing Unlimited (Gold) freeCE members, this CE option is included in your membership benefits at no additional cost! A password, which will be given at some point during this episode, is required to access the post-activity test. To earn credit for this episode, visit the following link below to go to freeCE's website: https://www.freece.com/ If you're not currently a freeCE member, we definitely suggest you explore all the benefits of their Unlimited Membership on their website and earn CE for listening to this podcast. Thanks for listening! If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. If you purchase an annual membership, you'll also get a free digital copy of High-Powered Medicine 3rd edition by Dr. Alex Poppen, PharmD. HPM is a book/website database of summaries for over 150 landmark clinical trials.You can visit our Patreon page at the website below:  www.patreon.com/corconsultrx We want to give a big thanks to Dr. Alex Poppen, PharmD and High-Powered Medicine for sponsoring the podcast..  You can get a copy of HPM at the links below:  Purchase a subscription or PDF copy - https://highpoweredmedicine.com/ Purchase the paperback and hardcover - Barnes and Noble website We want to say thank you to our sponsor, Pyrls. Try out their drug information app today. Visit the website below for a free trial: www.pyrls.com/corconsultrx We also want to thank our sponsor Freed AI. Freed is an AI scribe that listens, prepares your SOAP notes, and writes patient instructions. Charting is done before your patient walks out of the room. You can try 10 notes for free and after that it only costs $99/month. Visit the website below for more information: https://www.getfreed.ai/  If you have any questions for Cole or me, reach out to us via e-mail: Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com

Recent years have seen a troubling resurgence of whooping cough and measles — diseases many thought were largely controlled — highlighting the continuing importance of vaccination, surveillance, and community education. This course reviews the latest evidence on global and local trends, explores the factors driving renewed outbreaks, and discusses the key roles of pharmacists in prevention and early detection. You will gain insights to be better prepared to support immunization efforts, patient counseling, and public health awareness in response to this resurgence.HOSTRachel Maynard, PharmDGameChangers Podcast Host and Clinical Editor, CEimpactLead Editor, PyrlsGUESTChristina O'Connor, PharmD, BCPS, BCIDPClinical Pharmacy ManagerMayo Clinic Pharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe recent epidemiologic trends in pertussis and measles resurgence and factors contributing to increased incidence.2. Identify the pharmacist's responsibilities for promoting vaccination, encouraging timely immunization, supporting outbreak prevention, and providing patient education.Rachel Maynard and Christina O'Connor have no relevant financial relationships to disclose.0.075 CEU/0.75 HrUAN: 0107-0000-26-038-H01-PInitial release date: 1/12/2026Expiration date: 1/12/2027Additional CPE details can be found here.

Recent years have seen a troubling resurgence of whooping cough and measles — diseases many thought were largely controlled — highlighting the continuing importance of vaccination, surveillance, and community education. This course reviews the latest evidence on global and local trends, explores the factors driving renewed outbreaks, and discusses the key roles of pharmacists in prevention and early detection. You will gain insights to be better prepared to support immunization efforts, patient counseling, and public health awareness in response to this resurgence.HOSTRachel Maynard, PharmDGameChangers Podcast Host and Clinical Editor, CEimpactLead Editor, PyrlsGUESTChristina O'Connor, PharmD, BCPS, BCIDPClinical Pharmacy ManagerMayo ClinicPRACTICE RESOURCEPurchase this course to receive the exclusive downloadable practice resource handout to use as a reference guide to the podcast CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation:If you are already enrolled in this course, click here to redeem your credit. To purchase this episode and claim your CPE credit, click here.  CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe recent epidemiologic trends in pertussis and measles resurgence and factors contributing to increased incidence.2. Identify the pharmacist's responsibilities for promoting vaccination, encouraging timely immunization, supporting outbreak prevention, and providing patient education.Rachel Maynard and Christina O'Connor have no relevant financial relationships to disclose.0.075 CEU/0.75 HrUAN: 0107-0000-26-038-H01-PInitial release date: 1/12/2026Expiration date: 1/12/2027Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

In this episode, Joshua Weber, PharmD, MBA-HCM, CSP, BCMTMS, 340B ACE, Senior Director, St. Luke's Health System, highlights the organization's future-ready pharmacy transformation, including paperless workflows, AI-enabled prior authorizations, EHR-integrated benefits investigations, and expanded specialty drug access for 5,000 more patients.

In this episode, Thomas Carey, PharmD, Senior Director, Pharmacy Services, UW Northern Illinois, shares how the organization elevated its Med to Bed discharge program using multidisciplinary coordination, driving a nearly 30% reduction in 30-day readmissions. He also discusses agility in 340B compliance, leveraging learners, and the future of pharmacy growth through technology, automation, and workforce investment.

In this episode, Liz Unruh is joined by Kelly Eagan, PharmD, BCPS, BCACP, CDCES, the lead clinical pharmacist at Riverside's Cardiology Pharmacotherapy Clinic (CPC). Discover how clinical pharmacists play a crucial role in patient care management, help manage chronic conditions, and optimize medication therapy to ensure best outcomes for patients. Tune in to understand the unique value they bring to the healthcare team!

Send us a textSchedule an Rx AssessmentPeptides, telemedicine, speed-to-market. Independent pharmacies have real profitability levers in 2026 but the winners will be the ones who can move fast and stay compliant.In this episode, Scotty Sykes, CPA, CFP, Bonnie Bond, CPA, MBA, and Austin Murray sit down with Dr. Nicolette Mathey, PharmD, CEO of Atrium24 to unpack what's changing right now in the compounding and wellness economy.We cover:Why peptides are exploding in demandWhat to know about BPC-157 and why many think FDA movement could be comingHow pharmacies can use telemedicine to keep patients from being captured by big direct-to-consumer platformsWhere compounding pharmacies are still thrivingSpeed to market without reckless riskMore About Our Guest:Dr. Nicolette Mathey started her career at Walgreens at age 16 and earned her PharmD from the University of Florida in 2010. After pioneering a successful Bedside Delivery program at BayCare Health Systems, she became the Director of Clinical Services at Pharmacy Development Services. There, she co-developed the Clinical Services Profit Ignitor and played a pivotal role in early data analytics. In 2017, Nicolette acquired Palm Harbor Pharmacy, transforming it from a contracts-only establishment in a Heat Zone to a thriving hub. She revamped its identity, introducing robust digital marketing, a multi-rep sales system, compounding, immunizations, NABP accreditation, Test & Treat, Pharmacogenomic (PGX) Testing, and more. In 2019, Nicolette founded ATRIUM24, initially offering business consulting to pharmacies. Focused on developing software to automate data analytics and launch Dotti, the industry's first CRM sales system tailored for pharmacies, she sold Palm Harbor Pharmacy to another independent owner in October 2023. With the official launch of Dotti in January 2024, Dr. Mathey continues to innovate, aiding pharmacies in maximizing their data for profitability and growth. Through ATRIUM24 and Dotti, she and her team “connect the dots” for sales and marketing initiatives, empowering pharmacies with cutting-edge tools. Stay connected with Nicolette, Atrium24, and Dotti: Nicolette's LinkedInAtrium24 WebsiteAtrium24 FacebookAtrium24 LinkedInStay connected with us: FacebookYouTube LinkedInInstagram More resources on this topic: Podcast – The Startup Compounding Pharmacy PlaybookPodcast – Inside the Fight for Compounding: Advocacy, Growth, and Regulation

Robert Mancini, PharmD, BCOP, FHOPA is the current President of HOPA and the Oncology Pharmacy Program Coordinator and PGY2 Oncology Residency Program Director at St Luke's Cancer Institute in Boise, ID. Dr. Mancini talks through his priorities for HOPA this year and the latest in the world of oncology!

On this episode Fred Goldstein invites Steve Kheloussi, PharmD, MBA, FAMCP, Principal Consultant at Kheloussi Consulting, LLC, in the first installment of our four-part series on rare diseases. We discuss a practical overview of Duchenne muscular dystrophy (DMD), the current treatment landscape, and the evidence gaps that complicate payer decision-making. We also touch on the importance of what patients and caregivers need to maintain function, reduce fatigue, and navigate the significant emotional and practical burdens of care. This podcast is supported by an independent medical education grant from ITF Therapeutics. AMCP offers CPE for this podcast through December 31, 2026. For additional information and to claim credit, please visit:  ⁠The Power of Partnership: Bridging Patients and Payers in Duchenne Muscular Dystrophy Management⁠. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

On this episode of Danatech Talks–a special series from The Huddle– Paola Acevedo, PharmD, CDCES, walks through how to simplify the process of prescribing diabetes technology. Paola discusses common pain points both clients and prescribers may face related to documentation, coverage and affordability, and accessibility. She also shares practical strategies, systems and workflows providers and practices can implement to help navigate through these potential challenges.This episode was supported by educational grant funding from Abbott.Explore the latest in diabetes technology as well as trainings and resources on danatech: danatech l Diabetes Technology Education for Healthcare ProfessionalsExplore danatech's technology affordability tool: Diabetes Technology Affordability OptionsListen to previous episodes of our Danatech Talks diabetes technology series: https://thehuddle.simplecast.com/episodes/basics-diabetes-technology-for-health-care-professionalshttps://thehuddle.simplecast.com/episodes/understanding-cgms-and-interpreting-data-for-beginners  Listen to more episodes of The Huddle at adces.org/perspectives/the-huddle-podcast.Learn more about ADCES and the many benefits of membership at adces.org/join. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

On this episode, we discuss tobacco use disorder and describe its clinical impact, common presentations, and underlying neurobiological mechanisms. We evaluate current guidelines and evidence-based treatment strategies for smoking cessation, including pharmacologic and behavioral interventions. We also compare and contrast the efficacy, safety profiles, and appropriate use of nicotine-replacement therapies, prescription pharmacotherapies, behavioral strategies, and long-term patient follow-up in smoking cessation. Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We have continued to partner with freeCE.com to provide listeners with the opportunity to claim 1-hour of continuing education credit for select episodes. For existing Unlimited (Gold) freeCE members, this CE option is included in your membership benefits at no additional cost! A password, which will be given at some point during this episode, is required to access the post-activity test. To earn credit for this episode, visit the following link below to go to freeCE's website: https://www.freece.com/ If you're not currently a freeCE member, we definitely suggest you explore all the benefits of their Unlimited Membership on their website and earn CE for listening to this podcast. Thanks for listening! If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. If you purchase an annual membership, you'll also get a free digital copy of High-Powered Medicine 3rd edition by Dr. Alex Poppen, PharmD. HPM is a book/website database of summaries for over 150 landmark clinical trials.You can visit our Patreon page at the website below:  www.patreon.com/corconsultrx We want to give a big thanks to Dr. Alex Poppen, PharmD and High-Powered Medicine for sponsoring the podcast..  You can get a copy of HPM at the links below:  Purchase a subscription or PDF copy - https://highpoweredmedicine.com/ Purchase the paperback and hardcover - Barnes and Noble website We want to say thank you to our sponsor, Pyrls. Try out their drug information app today. Visit the website below for a free trial: www.pyrls.com/corconsultrx We also want to thank our sponsor Freed AI. Freed is an AI scribe that listens, prepares your SOAP notes, and writes patient instructions. Charting is done before your patient walks out of the room. You can try 10 notes for free and after that it only costs $99/month. Visit the website below for more information: https://www.getfreed.ai/  If you have any questions for Cole or me, reach out to us via e-mail: Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com

We bring back our prior pharmacology discussion because it's so incredibly important for the conversations that are on the horizon over the next few weeks. In this continuation of our myeloma series, we begin our discussion about treatment options for multiple myeloma, focusing first on pharmacology. We are so thrilled to have a special guest, Kathryn Maples, PharmD, BCOP who is a clinical pharmacy specialist in Multiple Myeloma at the Winship Cancer Institute of Emory Healthcare in Atlanta, Georgia!Content:- What are common drugs we use in "triplet regimens"? "quadruple therapy"? - What considerations must we take into account when prescribing commonly used medications in myeloma? - How should we counsel our patients? - What about supportive care?- How and when do we make dose adjustments? - This episode is SO eye-opening about the "behind the scenes" of myeloma care that physicians do not seeWant to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodesLove what you hear? Tell a friend and leave a review on our podcast streaming platforms!Twitter: @TheFellowOnCallInstagram: @TheFellowOnCallListen in on: Apple Podcast, Spotify, and Google Podcast

Matt and Paul recap top pearls from a recent episode on Anticoagulation for Venous Thromboembolism with Dr. Tara Lech, PharmD. They also answer listener questions and share their picks of the week.  Picks of the week: Paul Recommends: Death Stranding 2: On the Beach (videogame) Matt Recommends: CJ Box novels about Joe Picket

GLP-1 drugs like Ozempic, Wegovy, and Zepbound are changing medicine — but at what cost? In this episode of The Exam Room Podcast, host Chuck Carroll sits down with Ben Urich, PharmD, PhD, to break down the real-world data behind the GLP-1 explosion. You'll learn: - How many people are actually using GLP-1 drugs - Why most users stop — and why that's starting to change - The true cost of GLP-1 medications to employers and health plans - Common and serious side effects to be aware of - Why GLP-1s are now being studied for Alzheimer's disease and addiction - What the future holds as more than 30 new drugs enter the pipeline This is a must-watch conversation for anyone considering GLP-1 medications, currently using Ozempic or Wegovy, or wondering where modern weight-loss medicine is headed next.